Jocelyn Berdeprado

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 74 citations · Full text

Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients

Nicholas C Chesnaye, Karolina Szummer, Peter Bárány et al. · Journal of the American Heart Association · 2019 · 69 citations · Full text

A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function

E. Vilar, Raja Mohammed Kaja Kamal, James Fotheringham et al. · Kidney International · 2021 · 60 citations

Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin

Jonathan Wong, Sivakumar Sridharan, Jocelyn Berdeprado et al. · Kidney International · 2016 · 58 citations · Full text